Active substances
Omega 3 acid ethyl esters + Soya oil + Triglycerides medium chain
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| LIPOPLUS 20 % Emulsion For Infusion | 100,80,20 g,g,g | Emulsion for infusion · Intravenous use | 1 Bottle | SAR 29.60 | NCE · Prescription | B. BRAUN | Valid |
| LIPOPLUS 20 % Emulsion For Infusion | 100,80,20 g,g,g | Emulsion for infusion · Intravenous use | 1 Bottle | SAR 49.80 | NCE · Prescription | B. BRAUN | Valid |
| LIPOPLUS 20 % Emulsion For Infusion | 100,80,20 g,g,g | Emulsion for infusion · Intravenous use | 1 Bottle | SAR 83.60 | NCE · Prescription | B. BRAUN | Valid |
Indications — CHI Daman Drug Formulary
ACUTE PANCREATITIS
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.